Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication

被引：8

作者：

Mistrulli, Raffaella ^{[1
]}

Ferrera, Armando ^{[1
]}

Muthukkattil, Melwyn Luis ^{[1
]}

Battistoni, Allegra ^{[1
]}

Gallo, Giovanna ^{[1
]}

Barbato, Emanuele ^{[1
]}

Spera, Francesco Raffaele ^{[1
]}

Magri, Damiano ^{[1
]}

机构：

[1] Sapienza Univ Rome, Clin & Mol Med Dept, I-00185 Rome, Italy

来源：

JOURNAL OF CLINICAL MEDICINE | 2024年 / 13卷 / 02期

关键词：

atrial fibrillation; hypertrophic cardiomyopathy; cardiac amyloidosis; catheter ablatio; OUTCOMES; EFFICACY; RISK; ARRHYTHMIAS; PREVALENCE; PREDICTORS; SAFETY; IMPACT; SCORE;

D O I：

10.3390/jcm13020501

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation (AF) is the most common arrhythmia in patients affected by cardiomyopathies. Reports estimate a prevalence of 27% in patients with hypertrophic cardiomyopathy (HCM) and 40% in patients with cardiac amyloidosis (CA). The presence of AF typically results in progressive functional decline, an increased frequency of hospitalizations for heart failure, and a higher thromboembolic risk. Medical management using mainly beta-blockers or amiodarone has produced variable outcomes and a high rate of recurrence. Catheter ablation reduces symptom burden and complications despite a moderate rate of recurrence. Recent evidence suggests that an early rhythm control strategy may lead to more favorable short- and long-term outcomes. In this review, we summarize contemporary data on the management of AF in patients with cardiomyopathy (HCM and CA) with particular reference to the timing and outcomes of ablation procedures.

引用

页数：11

共 59 条

[11]

Derejko P, 2013, KARDIOL POL, V71, P17

[12] Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression [J].

Di Donna, Paolo ;

Olivotto, Iacopo ;

Delcre, Sara Dalila Luisella ;

Caponi, Domenico ;

Scaglione, Marco ;

Nault, Isabelle ;

Montefusco, Antonio ;

Girolami, Francesca ;

Cecchi, Franco ;

Haissaguerre, Michel ;

Gaita, Fiorenzo .

EUROPACE, 2010, 12 (03) :347-355

[13] Effectiveness and Safety of Oral Anticoagulants in Cardiac Amyloidosis: Lights and Shadows [J].

Di Lisi, Daniela ;

Di Caccamo, Leandro ;

Damerino, Giuseppe ;

Portelli, Maria Cristina ;

Comparato, Francesco ;

Di Stefano, Vincenzo ;

Brighina, Filippo ;

Corrado, Egle ;

Galassi, Alfredo Ruggero ;

Novo, Giuseppina .

CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (08)

[14] Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long Term Outcome [J].

Dinshaw, Leon ;

Muenkler, Paula ;

Schaeffer, Benjamin ;

Klatt, Niklas ;

Jungen, Christiane ;

Dickow, Jannis ;

Tamenang, Annika ;

Schleberger, Ruben ;

Pecha, Simon ;

Pinnschmidt, Hans ;

Patten, Monica ;

Reichenspurner, Hermann ;

Willems, Stephan ;

Meyer, Christian .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (03) :1-13

[15] Atrial Fibrillation in Transthyretin Cardiac Amyloidosis Predictors, Prevalence, and Efficacy of Rhythm Control Strategies [J].

Donnellan, Eoin ;

Wazni, Oussama M. ;

Hanna, Mazen ;

Elshazly, Mohamed B. ;

Puri, Rishi ;

Saliba, Walid ;

Kanj, Mohamed ;

Vakamudi, Sneha ;

Patel, Divyang R. ;

Baranowski, Bryan ;

Cantillon, Daniel ;

Dresing, Thomas ;

Jaber, Wael A. .

JACC-CLINICAL ELECTROPHYSIOLOGY, 2020, 6 (09) :1118-1127

[16] Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis [J].

Donnellan, Eoin ;

Wazni, Oussama ;

Kanj, Mohamed ;

Elshazly, Mohamed B. ;

Hussein, Ayman ;

Baranowski, Bryan ;

Hanna, Mazen ;

Patel, Divyang ;

Trulock, Kevin ;

Martyn, Michael ;

Menon, Venu ;

Saliba, Walid ;

Jaber, Wael A. .

EUROPACE, 2020, 22 (02) :259-264

[17] No Association Between CHADS-VASc Score and Left Atrial Appendage Thrombus in Patients With Transthyretin Amyloidosis [J].

Donnellan, Eoin ;

Elshazly, Mohamed B. ;

Vakamudi, Sneha ;

Wazni, Oussama M. ;

Cohen, Joshua A. ;

Kanj, Mohamed ;

Hanna, Mazen ;

Baranowski, Bryan ;

Saliba, Walid ;

Jaber, Wael .

JACC-CLINICAL ELECTROPHYSIOLOGY, 2019, 5 (12) :1473-1474

[18] Atrial fibrillation in hypertrophic cardiomyopathy-A contemporary mini-review [J].

Dragasis, Stylianos ;

Vlachos, Konstantinos ;

Kariki, Ourania ;

Koskina, Stavroula ;

Zygouri, Andromahi ;

Patsiotis, Ilias G. ;

Anastasakis, Aris ;

Athanasopoulos, George ;

Ritsatos, Konstantinos ;

Letsas, Konstantinos ;

Efremidis, Michael .

HELLENIC JOURNAL OF CARDIOLOGY, 2022, 67 :66-72

[19] 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J].

Elliott, Perry M. ;

Anastasakis, Aris ;

Borger, Michael A. ;

Borggrefe, Martin ;

Cecchi, Franco ;

Charron, Philippe ;

Hagege, Albert Alain ;

Lafont, Antoine ;

Limongelli, Giuseppe ;

Mahrholdt, Heiko ;

McKenna, William J. ;

Mogensen, Jens ;

Nihoyannopoulos, Petros ;

Nistri, Stefano ;

Pieper, Petronella G. ;

Pieske, Burkert ;

Rapezzi, Claudio ;

Rutten, Frans H. ;

Tillmanns, Christoph ;

Watkins, Hugh .

EUROPEAN HEART JOURNAL, 2014, 35 (39) :2733-+

[20]

Fumagalli C., 2022, Eur. Heart J, V43, pehac544, DOI [10.1093/eurheartj/ehac544.1787, DOI 10.1093/EURHEARTJ/EHAC544.1787]

← 1 2 3 4 5 6 →